iSpecimen Inc. Reports Director Changes and Compensation Adjustments
Ticker: ISPC · Form: 8-K · Filed: Dec 30, 2024 · CIK: 1558569
Sentiment: neutral
Topics: management-change, compensation, governance
TL;DR
iSpecimen board shakeup and pay changes filed. Watch for new strategy.
AI Summary
On December 27, 2024, iSpecimen Inc. filed an 8-K report detailing changes in its board of directors and executive compensation. The filing indicates the departure of certain officers and directors, along with the election of new directors and adjustments to compensatory arrangements for key personnel. Specific details regarding the individuals involved and the financial implications of these changes are outlined within the report.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy, governance, or financial outlook, potentially impacting investor confidence and stock performance.
Risk Assessment
Risk Level: medium — Changes in leadership and compensation can introduce uncertainty regarding future company direction and financial performance.
Key Numbers
- 001-40501 — SEC File Number (Identifies the company's filing with the SEC.)
- 27-0480143 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- iSpecimen Inc. (company) — Registrant
- Delaware (jurisdiction) — State of Incorporation
- Woburn, MA (location) — Principal executive offices
- December 27, 2024 (date) — Date of earliest event reported
FAQ
Who are the specific directors or officers that have departed from iSpecimen Inc.?
The filing indicates the departure of certain officers and directors, but does not name them explicitly in the provided excerpt.
What are the key changes in the compensatory arrangements for iSpecimen Inc. officers?
The filing mentions adjustments to compensatory arrangements for certain officers, but the specific details of these changes are not provided in this excerpt.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on December 27, 2024.
What is the principal executive office address for iSpecimen Inc.?
The principal executive office address for iSpecimen Inc. is 8 Cabot Road, Suite 1800, Woburn, MA 01801.
What is the SIC code for iSpecimen Inc.?
The Standard Industrial Classification (SIC) code for iSpecimen Inc. is 8731, which falls under SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH.
Filing Stats: 449 words · 2 min read · ~1 pages · Grade level 11.2 · Accepted 2024-12-30 16:15:30
Key Financial Figures
- $0.0001 — registered Common Stock, par value $0.0001 per share ISPC The Nasdaq Stock Mar
Filing Documents
- ea0226317-8k_ispecimen.htm (8-K) — 23KB
- 0001213900-24-113489.txt ( ) — 192KB
- ispc-20241227.xsd (EX-101.SCH) — 3KB
- ispc-20241227_lab.xml (EX-101.LAB) — 33KB
- ispc-20241227_pre.xml (EX-101.PRE) — 22KB
- ea0226317-8k_ispecimen_htm.xml (XML) — 4KB
02(c). Appointment of Certain Officers
Item 5.02(c). Appointment of Certain Officers. On December 27, 2024, the Board of Directors (the "Board") of iSpecimen Inc. (the "Company"), by written consent, appointed Mr. Robert Bradley Lim, the Company's Chief Executive Officer, to the additional roles of Treasurer and Secretary of the Company in accordance with the Company's Second Amended and Restated Bylaws. There were no changes to Mr. Lim's compensation or other terms of employment in connection with this appointment.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: December 30, 2024 iSPECIMEN INC. By: /s/ Robert Bradley Lim Name: Robert Bradley Lim Title: Chief Executive Officer 2